Search results for “CD74” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 315 patents, we discovered top 38 key players by total patent application. Immunomedics, Inc., Cell Signaling Technology, Inc., Sutro Biopharma, Inc. are dominant in this area. They take 54.29% of the total patent filing.
Immunomedics, Inc.
New Jersey, United States
Patent: 108
Cell Signaling Technology, Inc.
Massachusetts, United States
Patent: 39
Sutro Biopharma, Inc.
California, United States
Patent: 24
IBC Pharmaceuticals, Inc.
New Jersey, United States
Patent: 20
Genmab A/S
Hovedstaden, Denmark
Patent: 13
The Board of Regents of The University of Texas System
Texas, United States
Patent: 13
Baxalta GmbH
ZURICH, Switzerland
Patent: 12
STARTUP
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 12
L'Oréal SA
France
Patent: 11
Baxalta, Inc.
Illinois, United States
Patent: 11
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 13 patents, we discovered top 1 start-ups by total patent application.
STARTUP
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 12
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 73 patents applied in the last 5 years. We discover 25 most active companies in this area. The fast-growing DRAGONFLY Therapeutics, Inc., Immunomedics, Inc., Chugai Pharmaceutical Co., Ltd. take 46.58% of patent filing during this period.
STARTUP
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 12
Immunomedics, Inc.
New Jersey, United States
Patent: 12
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 10
Sutro Biopharma, Inc.
California, United States
Patent: 8
Cell Signaling Technology, Inc.
Massachusetts, United States
Patent: 6
Les Laboratoires Servier SAS
France
Patent: 3
Novartis AG
Basel-Stadt, Switzerland
Patent: 3
GlaxoSmithKline Biologicals SA
Belgium
Patent: 2
University of Copenhagen
Hovedstaden, Denmark
Patent: 2
Osaka University
Osaka-fu, Japan
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 73 patents in last 5 years, we discover 19 new entrants. DRAGONFLY Therapeutics, Inc., Chugai Pharmaceutical Co., Ltd., Les Laboratoires Servier SAS are the most active new entrants in this area.
STARTUP
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 12
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 10
Les Laboratoires Servier SAS
France
Patent: 3
Novartis AG
Basel-Stadt, Switzerland
Patent: 3
Bcell Solutions, Inc.
United States
Patent: 2
Osaka University
Osaka-fu, Japan
Patent: 2
Yeda Research & Development Co. Ltd.
Israel
Patent: 2
Jinan University
Guangdong Sheng, China
Patent: 1
Innovent Biologics (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 1
MedImmune Ltd.
Cambridgeshire, United Kingdom
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 65 patents, we discovered top 15 universities and scientific research institutions by total patent application. University of Copenhagen, University of Birmingham, The Ohio State University are dominant in this area. They take 49.23% of the total patent filing.
University of Copenhagen
Hovedstaden, Denmark
Patent: 9
University of Birmingham
Birmingham, United Kingdom
Patent: 6
The Ohio State University
Ohio, United States
Patent: 5
The University of Queensland
Queensland, Australia
Patent: 2
Osaka University
Osaka-fu, Japan
Patent: 2
The Second Military Medical University
Shanghai Shi, China
Patent: 2
Oregon Health & Science University
Oregon, United States
Patent: 1
Keio University
Tokyo-to, Japan
Patent: 1
Vrije Universiteit Brussel
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 1
Jinan University
Guangdong Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: